Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in

M Iwano1, A Fischer, H Okada

  • 1Division of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee 37232, USA.

Insights

Targeting fibroblasts, the cells driving tissue fibrosis, offers a new therapeutic strategy. Selective elimination of fibroblast-specific protein 1 (FSP1) positive fibroblasts reduced organ scarring and improved function.

Area of Science:

  • Cell Biology
  • Organ Fibrosis
  • Tissue Repair

Background:

  • Progressive tissue fibrosis impairs organ function and can lead to failure.
  • Fibroblasts are implicated in producing fibrogenic collagens during tissue injury.

Purpose of the Study:

  • To investigate the selective elimination of fibroblasts at injury sites.
  • To assess the therapeutic potential of targeting FSP1(+) fibroblasts in organ fibrosis.

Main Methods:

  • Development of transgenic mice expressing herpesvirus thymidine kinase (DeltaTK) under the fibroblast-specific protein 1 (FSP1) promoter.
  • Selective killing of FSP1(+) fibroblasts using nucleoside analogs in vitro and during experimental renal fibrosis.
  • Quantification of fibroblast numbers, type I collagen deposition, and fibrosis extent.

Main Results:

  • Transgenic fibroblasts selectively expressed thymidine kinase and were susceptible to nucleoside analogs.
  • Exposure to nucleoside analogs reduced fibroblast numbers in fibrogenic kidney tissue.
  • Type I collagen deposition and the extent of fibrosis were significantly reduced.

Conclusions:

  • Fibroblast reduction via DNA chain termination highlights the role of cell division in fibrogenesis.
  • FSP1(+) fibroblasts are crucial in fibrosis development.
  • This study provides a proof of principle for targeting FSP1(+) fibroblasts as a novel therapeutic approach for tissue fibrosis.